Figure 2.
5-Fu-resistant cervical cancer cells show increased E6/E6 expressions. (A) CaSki parental cells and 5-Fu-resistant cells were treated with 5-Fu at 0, 2, 4, 8, 16, or 32 µM for 48 hrs. The cell viabilities were assessed by MTT assay. (B) Protein expressions of E6/E7 from CaSki parental- and 5-Fu-resistant cells were measured by Western blot. β-actin was a loading control. Results are shown as mean±SEM. *p<0.05; **p<0.01; ***p<0.001.